Search Results - "Őrfi, Lászlȯ"
-
1
Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
Published in Neoplasia (New York, N.Y.) (01-04-2014)“…Abstract The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer. However, the benefits of targeted…”
Get full text
Journal Article -
2
Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
Published in Journal of medicinal chemistry (22-05-2014)“…Although there is a significant effort in the design of a selective CDK9/CycT1 inhibitor, no compound has been proven to be a specific inhibitor of this kinase…”
Get full text
Journal Article -
3
Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Published in International journal of molecular sciences (01-07-2023)“…Primary open-angle glaucoma remains a global issue, lacking a definitive treatment. Increased intraocular pressure (IOP) is considered the primary risk factor…”
Get full text
Journal Article -
4
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Published in Cancer research (Chicago, Ill.) (15-03-2008)“…Protein kinases play important roles in tumor development and progression. A variety of members of this family of signal transduction enzymes serve as targets…”
Get full text
Journal Article -
5
Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro
Published in International journal of molecular sciences (13-12-2023)“…Tissue fibrosis is characterized by chronic fibroblast activation and consequently excessive accumulation of collagen-rich extracellular matrix. In vitro…”
Get full text
Journal Article -
6
Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
Published in Cell host & microbe (08-10-2014)“…Mycobacterium tuberculosis (Mtb) requires protein secretion systems like ESX-1 for intracellular survival and virulence. The major virulence determinant and…”
Get full text
Journal Article -
7
Integrating molecular diagnostics into anticancer drug discovery
Published in Nature reviews. Drug discovery (01-07-2010)“…Efforts to repeat the success of pioneering molecularly targeted cancer drugs, such as trastuzumab, for particular patient populations have been hampered by…”
Get full text
Journal Article -
8
The role of PI3K-Akt-mTOR axis in Warburg effect and its modification by specific protein kinase inhibitors in human and rat inflammatory macrophages
Published in International immunopharmacology (15-11-2024)“…•Expression of HIF-1α, NOS2 and inflammatory cytokines increased in inflammatory macrophages.•Increased expressions of HIF-1α, NOS2 and IP-10 were reduced by…”
Get full text
Journal Article -
9
Transient Agarose Spot (TAS) Assay: A New Method to Investigate Cell Migration
Published in International journal of molecular sciences (14-02-2022)“…Fibroblasts play a central role in diseases associated with excessive deposition of extracellular matrix (ECM), including idiopathic pulmonary fibrosis…”
Get full text
Journal Article -
10
A Closer Look at the Structure of Sterically Stabilized Liposomes: A Small-Angle X-ray Scattering Study
Published in The journal of physical chemistry. B (27-05-2010)“…The evaluation of the radial electron density profile of a drug containing a sterically stabilized liposomal system is described. Using synchrotron small-angle…”
Get full text
Journal Article -
11
Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters
Published in PloS one (05-09-2018)“…Drug resistant tuberculosis (TB) is a major worldwide health problem. In addition to the bacterial mechanisms, human drug transporters limiting the cellular…”
Get full text
Journal Article -
12
Small-Molecule Inhibitors of NADPH Oxidase 4
Published in Journal of medicinal chemistry (23-09-2010)“…NOX enzymes are the major contributors in many oxidative damage related diseases. Unfortunately, at present no specific NOX inhibitor is available. Here, we…”
Get full text
Journal Article -
13
Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance
Published in Biochemical pharmacology (01-08-2012)“…(A) ABCG2 confers gefitinib or pelitinib resistance. Intracellular efficiency of neratinib or vandetanib is not restricted by ABCG2. (B) EGFR inhibitors block…”
Get full text
Journal Article -
14
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells
Published in European journal of medicinal chemistry (27-01-2016)“…Melanoma is an aggressive form of skin cancer and it is generally associated with poor prognosis in patients with late-stage disease. Due to the increasing…”
Get full text
Journal Article -
15
DNA binding of sunitinib: Spectroscopic evidence via circular dichroism and nuclear magnetic resonance
Published in Journal of pharmaceutical and biomedical analysis (20-02-2018)“…•Plasmid DNA can be used in DNA-ligand binding experiments with certain considerations.•A two-step binding mechanism is proposed for sunitinib.•In the first…”
Get full text
Journal Article -
16
Synthesis and evaluation of a new class of MIF-inhibitors in activated macrophage cells and in experimental septic shock in mice
Published in European journal of medicinal chemistry (05-02-2023)“…Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine with enzymatic activities. Anti-inflammatory effects of MIF enzyme inhibitors…”
Get full text
Journal Article -
17
Targeted drug combination therapy design based on driver genes
Published in Oncotarget (03-09-2019)“…Targeted therapies against cancer types with more than one driver gene hold bright but elusive promise, since approved drugs are not available for all driver…”
Get full text
Journal Article -
18
Small molecule somatostatin receptor subtype 4 (sst4) agonists are novel anti-inflammatory and analgesic drug candidates
Published in Neuropharmacology (01-11-2020)“…We provided strong proof of concept evidence that somatostatin mediates potent analgesic and anti-inflammatory actions via its receptor subtype 4 (sst4)…”
Get full text
Journal Article -
19
Leads for antitubercular compounds from kinase inhibitor library screens
Published in Tuberculosis (Edinburgh, Scotland) (01-11-2010)“…Summary Discovering new drugs to treat tuberculosis more efficiently and to overcome multidrug resistance is a world health priority. To find antimycobacterial…”
Get full text
Journal Article -
20
Chemoenzymatic route to Tyrphostins involving lipase-catalyzed kinetic resolution of 1-phenylethanamine with alkyl cyanoacetates as novel acylating agents
Published in Tetrahedron: asymmetry (15-07-2015)“…[Display omitted] Ethyl and isopropyl cyanoacetates were tested as acylating agents in the kinetic resolution of racemic 1-phenylethanamine rac-1 catalyzed by…”
Get full text
Journal Article